Status:
NOT_YET_RECRUITING
Mechanistic Evaluation of Treatments for Acute Antibody-Mediated Rejection of the Kidney Transplant
Lead Sponsor:
Imperial College London
Collaborating Sponsors:
University of Cambridge
Viapath LLP
Conditions:
Transplant; Complication, Rejection
Eligibility:
All Genders
5+ years
Brief Summary
The best treatment for kidney failure is a kidney transplant, but a transplanted kidney only works for about 10 to 15 years on average. One of the reasons that a transplanted kidney can stop working i...
Detailed Description
Design: Prospective observational study of patients enrolled in TAR:GET-1 Objectives: TAR-GET-1 (starting in 2019) is a multi-centre UK clinical trial that will compare standard of care (SOC) treatme...
Eligibility Criteria
Inclusion
- All patients enrolled in TAR:GET-1 Signed informed consent prior to any study specific procedures.
Exclusion
- None
Key Trial Info
Start Date :
September 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
August 31 2028
Estimated Enrollment :
170 Patients enrolled
Trial Details
Trial ID
NCT04496037
Start Date
September 1 2020
End Date
August 31 2028
Last Update
August 3 2020
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.